glenmarkpharma.com

Glenmark Pharmaceuticals, founded in 1977 and headquartered in Mumbai, India, is a global pharmaceutical company that develops, manufactures, and markets pharmaceutical products. The company operates in over 25 countries across North America, South America, Europe, Asia, Africa, and the Middle East, with a strong focus on research and development of innovative medications. Glenmark specializes in various therapeutic areas and maintains a diverse portfolio of pharmaceutical products serving both business and consumer markets worldwide. Rajeev Sharma Senior Vice President and Chief Financial Officer - North America Laura Lester Senior Vice President & General Counsel - North America Jim Brown Senior Vice President Firas B Abulaban Senior Vice President and Corporate Quality Head of North America Bradley Nowels Vice President Institutional Sales – North America Vishal Arora Vice President of Business Development and Licensing Michael Pope Executive Director and Site Head – Monroe, NC Adam Subervi Chief Compliance Officer Fabio Moreno Executive Director and Head of the OTC Business Kathleen (Kathy) McKenna Senior Director – Human Resources INVESTORS Company Secretary & Compliance Officer ComplianceOfficer@glenmarkpharma.com Tel No.: +91 22 4018 9999 Fax No.: +91 22 4018 9986 REGISTRAR AND SHARE TRANSFER AGENTS KFIN Technologies Limited Selenium Building, Tower-B, Plot No 31 & 32,Financial District, Nanakramguda, Serilingampally, Hyderabad, Rangareddy, Telangana, India – 500 032. Email ID: einward.ris@kfintech.com Toll Free/ Phone Number : 1800 309 4001 WhatsApp Number : (91) 910 009 4099 KFINTECH Corporate Website: www.kfintech.com RTA Website: https://ris.kfintech.com Investor Support Centre (DIY Link) https://ris.kfintech.com/clientservices/isc BUSINESS DEVELOPMENT For queries related to collaboration and partnership, please email to : businessdevelopment.web@glenmarkpharma.com INVESTORS Company Secretary & Compliance Officer ComplianceOfficer@glenmarkpharma.com Tel ...